"Oncology Associates at Mercy Medical Center provides high-quality hematology and oncology care for cancer patients close to home."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
96
National Cancer Institute (NCI)
80
SWOG Cancer Research Network
22
Eastern Cooperative Oncology Group
15
ECOG-ACRIN Cancer Research Group
13
NSABP Foundation Inc
6
Wake Forest University Health Sciences
5
Academic and Community Cancer Research United
2
Astellas Pharma Inc
2
GOG Foundation
2
Hoffmann-La Roche
2
Clinical Trials at Oncology Associates at Mercy Medical Center
During the past decade, Oncology Associates at Mercy Medical Center conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 120 clinical trials were completed, i.e. on
average, 196.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 28 clinical trials were completed. i.e. 164.7%
of trials that started reached the finish line.
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Oncology Associates at Mercy Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 96 trials, followed by "National Cancer Institute (NCI)" with 80 trials
sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "Eastern Cooperative Oncology Group" with 15 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 15 trials sponsored. Other sponsors include 36 different institutions and
companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Associates at Mercy Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 170 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 64 different institutions and companies that were
collaborators in the rest 44 trials.
Clinical Trials Conditions at Oncology Associates at Mercy Medical Center
According to Clinical.Site data, the most researched conditions in "Oncology Associates at Mercy Medical Center" are
"Breast Cancer" (36 trials), "Lung Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Colorectal Cancer" (13 trials) and "Pain" (8 trials). Many other conditions were trialed in "Oncology Associates at Mercy Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Oncology Associates at Mercy Medical Center
Most popular intervention types in "Oncology Associates at Mercy Medical Center" are "Drug" (218 trials), "Other" (132 trials), "Biological" (95 trials), "Procedure" (44 trials) and "Radiation" (33 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (42 trials), "placebo" (34 trials), "Paclitaxel" (22 trials) and "Questionnaire Administration" (22 trials). Other intervention names were less common.
Clinical Trials Genders at Oncology Associates at Mercy Medical Center
The vast majority of trials in "Oncology Associates at Mercy Medical Center" are
216 trials for "All" genders, 43 trials for "Female" genders and 7 trials for "Male" genders.
Clinical Trials Status at Oncology Associates at Mercy Medical Center
Currently, there are NaN active trials in "Oncology Associates at Mercy Medical Center".
undefined are not yet recruiting,
26 are recruiting,
72 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 143 completed trials in Oncology Associates at Mercy Medical Center,
4 suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Associates at Mercy Medical Center, 10 "Phase 1"
clinical trials were conducted, 102 "Phase 2" clinical
trials and 142 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 8 trials that are defined as “Not Applicable".